6 Einträge gefunden

1. Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)

   1. Maffini, Enrico
   2. Labopin, Myriam
   3. Beelen, Dietrich Wilhelm
   4. Kroeger, Nicolaus
   5. Arat, Mutlu
   6. Wilson, Keith M O
   7. Bay, Jacques-Olivier

   2022 - Forschungsinformationssystem des UKE
2. Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries

   1. Muhsen, Ibrahim N
   2. Hashmi, Shahrukh K
   3. Niederwieser, Dietger
   4. Kroeger, Nicolaus
   5. Agrawal, Samir
   6. Pasquini, Marcelo C
   7. Atsuta, Yoshiko

   2020 - Forschungsinformationssystem des UKE
3. Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries

   1. Muhsen, Ibrahim N
   2. Hashmi, Shahrukh K
   3. Niederwieser, Dietger
   4. Kroeger, Nicolaus
   5. Agrawal, Samir
   6. Pasquini, Marcelo C
   7. Atsuta, Yoshiko

   2020 - Forschungsinformationssystem des UKE
4. Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia

   1. Gratwohl, Alois
   2. Duarte, Rafael
   3. Snowden, John A
   4. van Biezen, Anja
   5. Baldomero, Helen
   6. Apperley, Jane
   7. Cornelissen, Jan

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
5. Response Assessment in Myeloma: Practical Manual on Consistent Reporting in an Era of Dramatic Therapeutic Advances

   1. Garderet, Laurent
   2. D'Souza, Anita
   3. Jacobs, Paulette
   4. van Biezen, Anja
   5. Schönland, Stefan
   6. Kroeger, Nicolaus
   7. Morris, Curly

   2017 - Forschungsinformationssystem des UKE
6. Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

   1. Kharfan-Dabaja, Mohamed A
   2. Labopin, Myriam
   3. Bazarbachi, Ali
   4. Socie, Gerard
   5. Kroeger, Nicolaus
   6. Blaise, Didier
   7. Veelken, Hendrik

   2015 - Forschungsinformationssystem des UKE